
RELX Plc
RELX
Updated: 23/09/2026, 13:35:29
RELX Plc is a global enterprise that delivers data-driven analytical solutions and strategic decision-making instruments to professional and corporate clients across North America, Europe, and other international markets. Its operations are structured into four distinct divisions: Risk, Scientific, Technical & Medical (STM), Legal, and Exhibitions. The Risk division specializes in providing advanced analytical platforms and decision support systems. These tools leverage a blend of publicly available and industry-specific data, integrated with sophisticated technology and algorithms, to help clients assess and forecast potential risks. Through its Scientific, Technical & Medical unit, RELX furnishes crucial information and analytical insights designed to foster scientific advancement and improve healthcare outcomes for institutions and practitioners alike. The Legal sector provides comprehensive legal, regulatory, and commercial intelligence, alongside analytical capabilities, enabling clients to make informed choices and enhance their operational efficiency. Finally, the Exhibitions division manages a portfolio of events, merging in-person interactions with data-driven and digital resources. This approach assists attendees in exploring market trends, identifying products, and facilitating business transactions. Established in 1903, the company, originally named Reed Elsevier PLC, adopted its current identity, RELX PLC, in July 2015. Its global headquarters are situated in London, United Kingdom.
No summaries found.
- Share price
- $32.98
- Market cap
- $57.58B
- Exchange
- NYSE
- Currency
- USD
- CEO
- Erik Engstrom
- Employees
- 37,000
- IPO date
- 06/10/1994
- Beta
- 0.256
- Last dividend
- $0.00
- Day range
- $32.82 – $33.72
- 52-week range
- $27.57 – $47.97
- 1-day performance
- -1.29%
- 1-year performance
- 19.62%
- Current drawdown (1Y)
- -31.25%
- CIK
- 0000929869
- CUSIP
- 759530108
- ISIN
- US7595301083
- Created
- 07/12/2025, 13:57:16
- Last update
- 23/09/2026, 13:35:29
Track RELX Plc with an AI analyst
See which prediction-market events move RELX, how its filings map to real-world exposure, and what 12 AI strategies are doing with positions like it.
Free forever to follow AlphaBrain’s AI strategies. No card required.
RELX (RELX) Loses 11.4% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
Zacks Investment Research • STOCK • 14/05/2026, 12:35:20
RELX PLC (RELX) Discusses Business Services Strategy and Innovation in Fraud and Identity Solutions Transcript
Seeking Alpha • STOCK • 13/05/2026, 18:40:45
RELX: Time To Get In (Rating Upgrade)
Seeking Alpha • STOCK • 13/05/2026, 18:15:52
RELX Group enters into agreement to acquire French Legaltech company Doctrine
GlobeNewsWire • STOCK • 28/04/2026, 10:20:00
Cytora and LexisNexis Risk Solutions announce strategic relationship to enhance risk selection and automation for U.S. commercial insurers
PRNewsWire • STOCK • 23/04/2026, 11:00:00
RELX shares fall as upbeat trading update fails to lift sentiment
Proactive Investors • STOCK • 23/04/2026, 06:53:31
LexisNexis Risk Solutions Builds on Agenium Alliance with Expanded Medical Data Access for Life Insurers
PRNewsWire • STOCK • 16/04/2026, 17:37:00
Citi upgrades RELX to 'buy' as AI fears create buying opportunity in de-rated European media sector
Proactive Investors • STOCK • 08/04/2026, 09:27:53
RELX's Data Advantage Shields it From AI-Native Rivals, CFO Says
WSJ • STOCK • 26/02/2026, 05:21:00
RELX: An Undervalued Stock With Consistent Growth And Recurring Revenue
Seeking Alpha • STOCK • 23/02/2026, 10:54:00
LexisNexis Risk Solutions Launches AI-Powered Identity Management Platform for Healthcare
PRNewsWire • STOCK • 19/02/2026, 10:40:00
UK's RELX plans pay boost for CEO Engstrom, Sky News reports
Reuters • STOCK • 18/02/2026, 12:30:33